Does transcranial direct current stimulation improve functional locomotion in people with Parkinson's disease? A systematic review and meta-analysis.
Hyo Keun Lee, Se Ji Ahn, Yang Mi Shin and 2 others
PMID 31286974WHAT IT FOUND
tDCS gave a small short-term improvement in timed walking tests for people with Parkinson's disease, but no benefit was found at follow-up after at least 4 weeks.
Key findings
01Across 18 studies of 325 people with Parkinson's disease, active tDCS compared with sham showed a small short-term improvement in timed walking outcomes.
02The short-term effect was not sustained in six long-term comparisons assessed at least 4 weeks after the final session.
03Short-term walking outcomes improved more when tDCS targeted multiple brain regions than when it targeted a single brain region.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The review was not registered before data extraction and analysis were completed. Fourteen of 18 studies reported participants were on medication, and the authors noted medication may confound the tDCS results. Freezing of gait status was not consistent across studies: six excluded severe freezing, while 12 did not report it. The included studies used different brain targets, stimulation intensities, durations, session numbers and concurrent training types, so the optimal protocol is unclear. Only six studies reported long-term outcomes, so the long-term conclusion rests on a smaller evidence base. The authors reported relatively low risk of bias except for selective reporting.
The easy way to misread this
Do not read the small short-term improvement as proof that tDCS alone creates lasting gait benefits in Parkinson's disease. The long-term analysis was not positive, several studies combined tDCS with gait training, treadmill training or physical training, and fourteen of 18 studies reported participants were on medication, so the review cannot separate tDCS from those concurrent factors.